"The transition ... showcases real leadership in sustainable innovation." Colgate announces major change impacting all of its ...

On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating. Looking ahead to 2026, the firm said the biggest open question for consumer ...

Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, currently trading at a reasonable 21.6x earnings. CL’s science-based innovation ...

Colgate-Palmolive (CL) is drawing fresh attention as investors weigh its long dividend track record, its focus on science-based product development, and an upcoming quarterly earnings release ...

Colgate-Palmolive (India) has received an income tax demand of Rs 267.64 crore for FY22, primarily arising from transfer pricing adjustments and disallowance of certain expenses, the company said in a ...

Colgate used claymation to underscore a universal experience: People often leave their toothbrushes at home when traveling. Toe Jam films created three Instagram videos, a playful twist on "Home Alone ...

Colgate-Palmolive Company (NYSE:CL) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. On December 19, BofA raised its price target on Colgate-Palmolive Company ...

Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best January Dividend Stocks to Invest in. On December 18, JPMorgan raised its price target on Colgate-Palmolive Company (NYSE:CL) to $88 ...

Colgate-Palmolive is rated a Buy, trading at an attractive valuation after a 30% pullback from its peak, supported by strong brands, resilient financials, and Dividend King status. CL maintains robust ...

Multi-year funding will advance oral health, as oral diseases are among the most prevalent and overlooked noncommunicable diseases impacting 3.7 billion people globally.1 ...

Procter & Gamble has agreed to revise packaging of its Crest toothpaste brand under an agreement with Texas Attorney General ...

Fintel reports that on January 7, 2026, Piper Sandler upgraded their outlook for Colgate-Palmolive (NYSE:CL) from Neutral to Overweight. Analyst Price Forecast Suggests 15.17% Upside As of December 21 ...